Concepedia

Jing Peng

JP

Statistics

Publications

6

Citations

318

H-Index

6

Active since

2005

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Tianjin Medical University General Hospital

Capital Medical University

Jing Peng is an author at First Affiliated Hospital of Zhengzhou University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2005–2020

6

Publications

6

CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia

Daniel E. Lopes de Menezes, Jing Peng, Evelyn N. Garrett et al. · Clinical Cancer Research · 2005 · 112 citations · Full text

, , +16

Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells

Xi Xie, Jing Peng, Kaipeng Huang et al. · Molecular and Cellular Endocrinology · 2012 · 76 citations

, , +13

<p>High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas</p>

Daolin Si, Fei Yin, Jing Peng et al. · Cancer Management and Research · 2020 · 72 citations · Full text

, , +17

Estrogen metabolism in the human lung: impact of tumorigenesis, smoke, sex and race/ethnicity

Jing Peng, Sibele I. Meireles, Xia Xu et al. · Oncotarget · 2017 · 21 citations · Full text

, , +17

IL-23 and IL-27 Levels in Serum are Associated with the Process and the Recovery of Guillain-Barré Syndrome

Jing Peng, Hui Zhang, Peidong Liu et al. · Scientific Reports · 2018 · 20 citations · Full text

, , +16

1–5 of 6